当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 2018年第19期
编号:13336917
补肾壮骨汤治疗糖尿病性骨质疏松症的临床效果(1)
http://www.100md.com 2018年10月1日 《糖尿病新世界》 2018年第19期
     [摘要] 目的 分析讨论对糖尿病性骨质疏松症患者使用补肾壮骨汤的具体效果。 方法 选取该院2015年1月—2017年12月糖尿病性骨质疏松症患者50例,根据入院先后将其均分为两组,每组25例,1组为对照组,给予患者常规治疗;2组为观察组,在上述治疗前提下给予患者补肾壮骨汤。比较两组患者治疗前后骨密度、血清钙水平和总有效率。 结果 治疗前,两组患者骨密度和血清钙水平差异无统计学意义(P>0.05);治疗后,观察组骨密度和血清钙水平明显高于对照组,差异有统计学意义(P<0.05)。观察组和对照组总有效率依次为96.00%和72.00%,观察组明显高于对照组,差异有统计学意义(P<0.05)。结论 对糖尿病性骨质疏松症患者使用补肾壮骨汤可以提升骨密度和血清钙水平,治疗效果显著,可在临床上进行全面推广。

    [关键词] 补肾壮骨汤;糖尿病性骨质疏松症;肾虚

    [中图分类号] R580 [文献标识码] A [文章编号] 1672-4062(2018)10(a)-0073-02

    [Abstract] Objective To analyze and discuss the specific effect of bushen zhuanggu decoction in treatment of diabetic osteoporosis. Methods 50 cases of patients with diabetic osteoporosis admitted and treated in our hospital from January 2015 to December 2017 were selected and divided into two groups with 25 cases in each, the control group used the routine therapy, while the observation group used the bushen zhuanggu decoction on the basis of the control group, and the bone density, calcium serum level and total effective rate were compared between the two groups. Results Before treatment, the differences in the bone density and calcium serum levels between the two groups were not obvious(P>0.05), after treatment, the bone density and calcium serum level in the observation group were obviously higher than those in the control group,the different was statistically significant(P<0.05), and the total treatment effective rate in the observation group and in the control group was respectively 96.00%, 72.00%, and the index in the observation group was obviously higher than that in the control group,the different was statistically significant(P<0.05). Conclusion The bushen zhuanggu decoction in treatment of diabetic osteoporosis can improve the bone density and calcium serum level, and the treatment effect is obvious, and it is worth comprehensive promotion in clinic.

    [Key words] Bushen zhuanggu decoction; Diabetic osteoporosis; Kidney deficiency

    我國人口平均年龄逐渐升高,而且随着生活方式改变,糖尿病发病率呈直线上升趋势,严重损害老年人生活质量。糖尿病骨质疏松症是糖尿病常见并发症,属于代谢性骨骼类疾病,影响骨骼系统功能[1]。该疾病主要表现骨量减少等骨结构受损,而且还会对患者造成功能性障碍,甚至还可能致死、致残。现阶段对于糖尿病性骨质疏松症无特效疗法,一般只能通过降糖、补钙等方式进行对症治疗[2]。在中医研究范畴中,该疾病与肾存在联系,可以通过滋补肝肾来进行治疗。该院对糖尿病性骨质疏松症患者使用补肾壮骨汤,现报道如下。

    1 资料与方法

    1.1 一般资料

    选取糖尿病性骨质疏松症患者50例为研究对象,根据入院先后将其均分为两组,每组25例,1组为对照组,2组为观察组。其中,对照组男女比例为14∶11,年龄52~67岁,平均年龄(58.9±3.6)岁;观察组男女比例为15∶10,年龄51~68岁,平均年龄(58.8±3.9)岁,两组患者在基础信息上差异无统计学意义(P>0.05),可进行对比。

    1.2 方法

    1.2.1 对照组 采用基础治疗。包括饮食治疗、运动治疗、糖尿病教育等。并口服二甲双胍片(0.25 g/片,批号:国药准字H10980064),3次/d,1片/次。持续服药3月。, http://www.100md.com(利瑞贞)
1 2下一页